159 related articles for article (PubMed ID: 7044594)
1. VP16-213 (etoposide). A critical review of its activity.
Cavalli F
Cancer Chemother Pharmacol; 1982; 7(2-3):81-5. PubMed ID: 7044594
[No Abstract] [Full Text] [Related]
2. Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Am J Obstet Gynecol; 1984 Dec; 150(8):924-7. PubMed ID: 6095666
[TBL] [Abstract][Full Text] [Related]
3. Review of etoposide single-agent activity.
Schmoll H
Cancer Treat Rev; 1982 Jun; 9 Suppl():21-30. PubMed ID: 6751532
[No Abstract] [Full Text] [Related]
4. Phase II study of VP16-213 (etoposide) in refractory metastatic breast carcinoma.
Schell FC; Yap HY; Hortobagyi GN; Issell B; Esparza L
Cancer Chemother Pharmacol; 1982; 7(2-3):223-5. PubMed ID: 7083463
[No Abstract] [Full Text] [Related]
5. Etoposide: a new anti-cancer agent.
Arnold AM; Whitehouse JM
Lancet; 1981 Oct; 2(8252):912-5. PubMed ID: 6117692
[No Abstract] [Full Text] [Related]
6. VP16-213 as a single agent in advanced testicular tumors.
Fitzharris BM; Kaye SB; Saverymuttu S; Newlands ES; Barrett A; Peckham MJ; McElwain TJ
Eur J Cancer (1965); 1980 Sep; 16(9):1193-7. PubMed ID: 7227446
[No Abstract] [Full Text] [Related]
7. Simple method for the administration of high-dose etoposide during autologous bone marrow transplantation.
Lazarus HM; Creger RJ; Diaz D
Cancer Treat Rep; 1986 Jun; 70(6):819-20. PubMed ID: 3524832
[No Abstract] [Full Text] [Related]
8. Etoposide (VP-16-213).
Issell BF; Crooke ST
Cancer Treat Rev; 1979 Jun; 6(2):107-24. PubMed ID: 385138
[No Abstract] [Full Text] [Related]
9. [Phase II study of etoposide in patients with lung cancer, with special reference to small cell carcinoma].
Kurita Y; Yokoyama A; Kinameri K; Matsuura N; Sano K
Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):108-11. PubMed ID: 3009665
[No Abstract] [Full Text] [Related]
10. A phase I trial of continuous infusion VP16-213 (etoposide).
Aisner J; Van Echo DA; Whitacre M; Wiernik PH
Cancer Chemother Pharmacol; 1982; 7(2-3):157-60. PubMed ID: 7083457
[TBL] [Abstract][Full Text] [Related]
11. Podophyllotoxin derivative VP 16-213.
Arnold AM
Cancer Chemother Pharmacol; 1979; 3(2):71-80. PubMed ID: 389478
[TBL] [Abstract][Full Text] [Related]
12. [Etoposide: VP-16].
Dicato M
Bull Soc Sci Med Grand Duche Luxemb; 1982; 119(2):15-8. PubMed ID: 7160031
[No Abstract] [Full Text] [Related]
13. The podophyllotoxin derivatives VP16-213 and VM26.
Issell BF
Cancer Chemother Pharmacol; 1982; 7(2-3):73-80. PubMed ID: 7044593
[TBL] [Abstract][Full Text] [Related]
14. [A phase II trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia].
Moriyama Y; Shibata A; Maekawa I; Yoshida Y; Miura A; Wakui A; Kariyone S; Maekawa T; Miura Y; Abe T
Rinsho Ketsueki; 1985 Nov; 26(11):1774-84. PubMed ID: 3835288
[No Abstract] [Full Text] [Related]
15. A review of etoposide in patients with non-small-cell lung cancer (NSCLC).
Itri LM; Gralla RJ
Cancer Treat Rev; 1982 Jun; 9 Suppl():115-8. PubMed ID: 6889916
[No Abstract] [Full Text] [Related]
16. Lack of severe hypotension with VP-16-213 administered directly lv.
Cavalli F; Sonntag RW; Ryssel HJ; Brunner KW
Cancer Treat Rep; 1977 Oct; 61(7):1411. PubMed ID: 589604
[No Abstract] [Full Text] [Related]
17. Phase I trial of a new form of an oral administration of VP-16-213.
Lau ME; Hansen HH; Nissen NI; Pedersen H
Cancer Treat Rep; 1979 Mar; 63(3):485-7. PubMed ID: 371801
[TBL] [Abstract][Full Text] [Related]
18. Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors.
Bremer K; Niederle N; Krischke W; Higi M; Scheulen ME; Schmidt CG; Seeber S
Cancer Treat Rev; 1982 Jun; 9 Suppl():79-84. PubMed ID: 7127338
[No Abstract] [Full Text] [Related]
19. Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC).
Chapman R; Itri L; Gralla R; Kelsen D; Casper E; Golbey R
Cancer Chemother Pharmacol; 1982; 7(2-3):205-7. PubMed ID: 7083460
[TBL] [Abstract][Full Text] [Related]
20. [Prospects of new chemotherapies].
Sculier JP; Klastersky J
Rev Med Brux; 1982 Oct; 3(8):519-27. PubMed ID: 6897459
[No Abstract] [Full Text] [Related]
[Next] [New Search]
